Literature DB >> 19188672

Sunitinib-induced hemoglobin changes are related to the dosing schedule.

Astrid A M van der Veldt, Epie Boven, Laura Vroling, Henk J Broxterman, Alfons J M van den Eertwegh, John G Haanen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19188672     DOI： 10.1200/JCO.2008.20.6151

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Targeted therapies in renal cell cancer: recent developments in imaging.

Authors:  Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven
Journal:  Target Oncol       Date:  2010-07-14       Impact factor: 4.493

2.  Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study.

Authors:  Bibian M E Tullemans; Sanne L N Brouns; Frauke Swieringa; Siamack Sabrkhany; Franchette W P J van den Berkmortel; Natascha A J B Peters; Peter de Bruijn; Stijn L W Koolen; Johan W M Heemskerk; Maureen J B Aarts; Marijke J E Kuijpers
Journal:  BMC Cancer       Date:  2022-06-13       Impact factor: 4.638

3.  Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.

Authors:  Sumita S Bhatta; Kristen E Wroblewski; Kelly L Agarwal; Laura Sit; Ezra E W Cohen; Tanguy Y Seiwert; Theodore Karrison; George L Bakris; Mark J Ratain; Everett E Vokes; Michael L Maitland
Journal:  Oncologist       Date:  2013-07-30

4.  Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.

Authors:  Yutaka Fujiwara; Naomi Kiyota; Naoko Chayahara; Akiyuki Suzuki; Yoshiko Umeyama; Toru Mukohara; Hironobu Minami
Journal:  Invest New Drugs       Date:  2011-02-08       Impact factor: 3.850

5.  Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study.

Authors:  Alison C Johnson; Margarida Matias; Helen Boyle; Bernard Escudier; Alicia Molinier; Brigitte Laguerre; Carole Helissey; Pierre-Emmanuel Brachet; Audrey Emmanuelle Dugué; Loic Mourey; Elodie Coquan; Florence Joly
Journal:  BMC Cancer       Date:  2017-05-22       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.